In Vivo Photoadduction of Anesthetic Ligands in Mouse Brain Markedly Extends Sedation and Hypnosis.
Andrew R McKinstry-WuAndrzej Z WasilczukWilliam P DaileyRoderic G EckenhoffMax B KelzPublished in: The Journal of neuroscience : the official journal of the Society for Neuroscience (2023)
Photoaffinity ligands are best known as tools used to identify the specific binding sites of drugs to their molecular targets. However, photoaffinity ligands have the potential to further define critical neuroanatomic targets of drug action. In the brains of wild type male mice, we demonstrate the feasibility of using photoaffinity ligands in vivo to prolong anesthesia via targeted yet spatially-restricted photoadduction of azi- m -propofol (aziPm), a photoreactive analog of the general anesthetic propofol. Systemic administration of aziPm with bilateral near-ultraviolet photoadduction in the rostral pons, at the border of the parabrachial nucleus and locus coeruleus, produced a twenty-fold increase in the duration of sedative and hypnotic effects compared to control mice without UV illumination. Photoadduction that missed the parabrachial-coerulean complex also failed to extend the sedative or hypnotic actions of aziPm and was indistinguishable from non-adducted controls. Paralleling the prolonged behavioral and electroencephalographic consequences of on target in vivo photoadduction, we conducted electrophysiologic recordings in rostral pontine brain slices. Using neurons within the locus coeruleus to further highlight the cellular consequences of irreversible aziPm binding, we demonstrate transient slowing of spontaneous action potentials with a brief bath application of aziPm that becomes irreversible upon photoadduction. Together, these findings suggest photochemistry-based strategies are a viable new approach for probing CNS physiology and pathophysiology. Significance Statement Photoaffinity ligands are drugs capable of light-induced irreversible binding, which have unexploited potential to identify the neuroanatomic sites of drug action. We systemically administer a centrally-acting anesthetic photoaffinity ligand in mice, conduct localized photoillumination within the brain to covalently adduct the drug at its in vivo sites of action, and successfully enrich irreversible drug binding within a restricted 250µm radius. When photoadduction encompassed the pontine parabrachial-coerulean complex, anesthetic sedation and hypnosis was prolonged twenty-fold, thus illustrating the power of in vivo photochemistry to help unravel neuronal mechanisms of drug action.
Keyphrases
- wild type
- drug induced
- cerebral ischemia
- adverse drug
- white matter
- blood brain barrier
- risk assessment
- dna binding
- adipose tissue
- insulin resistance
- single molecule
- binding protein
- molecular dynamics simulations
- resting state
- drug delivery
- emergency department
- intensive care unit
- electronic health record
- genome wide association study